YourLawyer.com® 1-800-LAW-INFO (1-800-529-4636)
Parker Waichman Alonso LLP Headlines by Topic
Vioxx
Merck Not the Only Drug Company to Use "Ghostwriters"
Apr 18, 2008 | Parker Waichman Alonso LLP
Earlier this week, it was learned Merck & Company conducted research on Vioxx, and the concealed it role in the studies by paying prominent...
FDA Considering Biomarkers As a Way to Improve Drug Safety
Apr 17, 2008 | Parker Waichman Alonso LLP
A new way of testing experimental drugs is being considered by the Food & Drug Administration (FDA). If adopted, the FDA could end up...
Merck Deception in Vioxx Studies Detailed
Apr 16, 2008 | Parker Waichman Alonso LLP
Merck Inc. concealed mortality risks in two key Vioxx studies, and hired "ghostwriters" to author research that was supposedly conducted by...
Vioxx Settlement Meets Vital Deadline
Mar 6, 2008 | Parker Waichman Alonso LLP
The Vioxx settlement passed yet another milestone. Enough people have signed on to Merck & Co.'s pending $4.85 billion Vioxx...
Vioxx Lawsuit Settlement Deadline Extended
Feb 22, 2008 | Parker Waichman Alonso LLP
Vioxx plaintiffs have some more time to apply for a settlement over the defective drug. Lawyers now have an extra month to submit paperwork for...
Florida Vioxx Plaintiffs Look to Expand Settlement
Jan 30, 2008 | Parker Waichman Alonso LLP
Vioxx plaintiffs in Florida are petitioning a federal court to expand Merck’s proposed $4.85 billion settlement to include those who did not...
Vioxx Settlement Gaining Ground, with 95 Percent of Plaintiffs Signing On
Jan 22, 2008 | Parker Waichman Alonso LLP
The pending Merck Vioxx settlement appears to be on track, as more than 95 percent of possible Vioxx claimants have signed on to Merck’s $4.85...
Celebrex, other COX-2 Inhibitors May Cause Heart Arrhythmias
Jan 17, 2008 | Parker Waichman Alonso LLP
Research on fruit flies and rats has found that COX-2 inhibitors, a class of painkillers that includes Celecoxib (brand name Celebrex) and the...
Big Vioxx Settlement Deadline Today
Jan 15, 2008 | Parker Waichman Alonso LLP
Vioxx patients who where injured by the defective drug have until the end of business today to decide whether or not to take part in a proposed $4.85...
Deadlines Mean Vioxx Lawsuit Plaintiffs Have Big Decisions to Make
Jan 10, 2008 | Parker Waichman Alonso LLP
With deadlines looming, many people injured by Vioxx will need to decide if they want to be part of the $4.85 billion settlement that Merck proposed...
Page 4/35 [first] [prev] 1 2 3 4 5 6 7 8 9 10 ... [next] [last]
Vioxx
